{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:41:26Z","timestamp":1789519286827,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":2437,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1124\/dmd.117.079400","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T15:40:19Z","timestamp":1520869219000},"page":"600-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of Structural and Molecular Features Involved in the Transport of 3\u2032-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3"],"prefix":"10.1016","volume":"46","author":[{"given":"MD Fazlur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajgopal","family":"Govindarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.117.079400_bib1","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1021\/jm9600095","article-title":"Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogs","volume":"40","author":"Adams","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.117.079400_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejmech.2015.05.042","article-title":"Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer","volume":"100","author":"Agarwal","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"Suppl 1","key":"10.1124\/dmd.117.079400_bib3","first-page":"3","article-title":"[Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection]","volume":"14","author":"Aguirrebengoa","year":"1996","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1124\/dmd.117.079400_bib4","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/ja00721a600","article-title":"3\u2032-deoxy-3\u2032-(dihydroxyphosphinylmethyl)nucleosides. Isosteric phosphonate analogs of nucleoside 3\u2032-phosphates","volume":"92","author":"Albrecht","year":"1970","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.117.079400_bib5","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1128\/JVI.01968-08","article-title":"The human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogs","volume":"83","author":"Ambrose","year":"2009","journal-title":"J Virol"},{"key":"10.1124\/dmd.117.079400_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/COH.0b013e3282f85dc1","article-title":"Recent developments in the clinical pharmacology of anti-HIV nucleoside analogs","volume":"3","author":"Anderson","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1124\/dmd.117.079400_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1248\/cpb.56.423","article-title":"Design, synthesis and anti flaviviridae activity of N(6)-, 5\u2032,3\u2032-O- and 5\u2032,2\u2032-O-substituted adenine nucleoside analogs","volume":"56","author":"Angusti","year":"2008","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/dmd.117.079400_bib8","doi-asserted-by":"crossref","first-page":"e0136779","DOI":"10.1371\/journal.pone.0136779","article-title":"The role of flexible loops in folding, trafficking and activity of equilibrative nucleoside transporters","volume":"10","author":"Aseervatham","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/dmd.117.079400_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00424-003-1103-2","article-title":"The equilibrative nucleoside transporter family, SLC29","volume":"447","author":"Baldwin","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.117.079400_bib10","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1074\/jbc.M414337200","article-title":"Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes","volume":"280","author":"Baldwin","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.117.079400_bib11","doi-asserted-by":"crossref","unstructured":"Bavoux F, Loubeyre-Unique C, Blanche S (2000) Antiretroviral drugs and pregnancy: apropos of an alert regarding mitochondrial pathology and nucleoside analogs. Arch Pediatr 7 (Suppl 2):407s\u2013408s.","DOI":"10.1016\/S0929-693X(00)80118-9"},{"key":"10.1124\/dmd.117.079400_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.antiviral.2011.08.012","article-title":"The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication","volume":"92","author":"Billioud","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1124\/dmd.117.079400_bib13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1749-6632.1975.tb29225.x","article-title":"Experimental and clinical studies on nucleoside analogs as antitumor agents","volume":"255","author":"Burchenal","year":"1975","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/dmd.117.079400_bib14","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1093\/hmg\/dds326","article-title":"Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis","volume":"21","author":"Campeau","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1124\/dmd.117.079400_bib15","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.3892\/etm.2015.2379","article-title":"Efficacy and safety of nucleoside analogs on blocking father-to-infant vertical transmission of hepatitis B virus","volume":"9","author":"Cao","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1124\/dmd.117.079400_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0609.1992.tb00034.x","article-title":"Antiviral nucleoside toxicity in canine bone marrow progenitor cells and its relationship to drug permeation","volume":"49","author":"Chan","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1124\/dmd.117.079400_bib17","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/hmg\/ddp161","article-title":"SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway","volume":"18","author":"Cliffe","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1124\/dmd.117.079400_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0166-3542(95)00836-5","article-title":"Mechanisms for the anti-hepatitis B virus activity and mitochondrial toxicity of fialuridine (FIAU)","volume":"29","author":"Colacino","year":"1996","journal-title":"Antiviral Res"},{"key":"10.1124\/dmd.117.079400_bib19","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/AAC.38.9.1997","article-title":"Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture","volume":"38","author":"Colacino","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.117.079400_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2010.09.009","article-title":"Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: high-affinity inhibitors of human concentrative nucleoside transporter 1","volume":"81","author":"Damaraju","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.117.079400_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00492-17","article-title":"Nucleotide substrate specificity of anti-hepatitis C virus nucleoside analogs for human mitochondrial RNA polymerase","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.117.079400_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1124\/mol.104.008102","article-title":"Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole","volume":"67","author":"Endres","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.117.079400_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.leu.2402114","article-title":"Nucleoside analogues: mechanisms of drug resistance and reversal strategies","volume":"15","author":"Galmarini","year":"2001","journal-title":"Leukemia"},{"key":"10.1124\/dmd.117.079400_bib24","first-page":"1136","article-title":"Severe toxicity of fialuridine (FIAU)","volume":"334","author":"Gordon","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.117.079400_bib25","doi-asserted-by":"crossref","first-page":"G910","DOI":"10.1152\/ajpgi.90672.2008","article-title":"Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3","volume":"296","author":"Govindarajan","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.117.079400_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00424-003-1107-y","article-title":"The concentrative nucleoside transporter family, SLC28","volume":"447","author":"Gray","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.117.079400_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nature22057","article-title":"Visualizing multistep elevator-like transitions of a nucleoside transporter","volume":"545","author":"Hirschi","year":"2017","journal-title":"Nature"},{"key":"10.1124\/dmd.117.079400_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199717010-00001","article-title":"Mitochondrial injury. Lessons from the fialuridine trial","volume":"17","author":"Honkoop","year":"1997","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.117.079400_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.1213682","article-title":"Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis","volume":"335","author":"Hsu","year":"2012","journal-title":"Science"},{"key":"10.1124\/dmd.117.079400_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature10882","article-title":"Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 \u00c5","volume":"483","author":"Johnson","year":"2012","journal-title":"Nature"},{"key":"10.1124\/dmd.117.079400_bib31","doi-asserted-by":"crossref","first-page":"28343","DOI":"10.1074\/jbc.M110.109199","article-title":"Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability","volume":"285","author":"Kang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.117.079400_bib32","first-page":"192","article-title":"Histopathologic changes associated with fialuridine hepatotoxicity","volume":"10","author":"Kleiner","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1124\/dmd.117.079400_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425255.2012.680885","article-title":"The role of transporters in the toxicity of nucleoside and nucleotide analogs","volume":"8","author":"Koczor","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.117.079400_bib34","doi-asserted-by":"crossref","first-page":"22127","DOI":"10.1016\/S0021-9258(20)80657-7","article-title":"Enzymic cleavage as a probe of the molecular structures of mammalian equilibrative nucleoside transporters","volume":"268","author":"Kwong","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.117.079400_bib35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1124\/mol.65.4.925","article-title":"Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line","volume":"65","author":"Lang","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.117.079400_bib36","doi-asserted-by":"crossref","first-page":"16700","DOI":"10.1074\/jbc.M513825200","article-title":"Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine","volume":"281","author":"Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.117.079400_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002800050040","article-title":"Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles","volume":"45","author":"Lum","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.117.079400_bib38","first-page":"2789","article-title":"Combination antiretroviral therapy for HIV infection","volume":"57","author":"Maenza","year":"1998","journal-title":"Am Fam Physician"},{"key":"10.1124\/dmd.117.079400_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejphar.2003.08.076","article-title":"Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney","volume":"479","author":"Mangravite","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.117.079400_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ajhg.2008.09.013","article-title":"The H syndrome is caused by mutations in the nucleoside transporter hENT3","volume":"83","author":"Molho-Pessach","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1124\/dmd.117.079400_bib41","doi-asserted-by":"crossref","first-page":"e1000833","DOI":"10.1371\/journal.pgen.1000833","article-title":"Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease","volume":"6","author":"Morgan","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1124\/dmd.117.079400_bib42","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1021\/mp200647a","article-title":"Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-\/-) mice","volume":"9","author":"Moss","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.117.079400_bib43","doi-asserted-by":"crossref","unstructured":"Pastor-Anglada M, Cano-Soldado P, Errasti-Murugarren E, Casado FJ (2008) SLC28 genes and concentrative nucleoside transporter (CNT) proteins. Xenobiotica 38:972\u2013994.","DOI":"10.1080\/00498250802069096"},{"key":"10.1124\/dmd.117.079400_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cld.2004.02.012","article-title":"Antiviral therapy: nucleotide and nucleoside analogs","volume":"8","author":"Quan","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1124\/dmd.117.079400_bib45","doi-asserted-by":"crossref","first-page":"14775","DOI":"10.1074\/jbc.M117.787952","article-title":"Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3","volume":"292","author":"Rahman","year":"2017","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"10.1124\/dmd.117.079400_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0192-0561(91)90132-Q","article-title":"Immune-associated toxicities induced by in vivo and in vitro exposure to interferon-alpha alone or in combination with nucleoside analogs","volume":"13","author":"Sanders","year":"1991","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/dmd.117.079400_bib47","doi-asserted-by":"crossref","unstructured":"Singh A, Govindarajan R (2017) ENT3 utilizes a pH sensing mechanism for transport. Channels 12:78\u201380.","DOI":"10.1080\/19336950.2017.1389581"},{"key":"10.1124\/dmd.117.079400_bib48","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbrc.2014.06.098","article-title":"Down-regulation of mitochondrial thymidine kinase 2 and deoxyguanosine kinase by didanosine: implication for mitochondrial toxicities of anti-HIV nucleoside analogs","volume":"450","author":"Sun","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.117.079400_bib49","doi-asserted-by":"crossref","first-page":"21519","DOI":"10.1074\/jbc.273.34.21519","article-title":"Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs","volume":"273","author":"Sundaram","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.117.079400_bib50","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0026-895X(25)09252-1","article-title":"Transport of the antiviral nucleoside analogs 3\u2032-azido-3\u2032-deoxythymidine and 2\u2032,3\u2032-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes","volume":"50","author":"Yao","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.117.079400_bib51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/09687680110048318","article-title":"Transport of antiviral 3\u2032-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes","volume":"18","author":"Yao","year":"2001","journal-title":"Mol Membr Biol"},{"key":"10.1124\/dmd.117.079400_bib52","doi-asserted-by":"crossref","first-page":"24938","DOI":"10.1074\/jbc.M200966200","article-title":"Functional and molecular characterization of nucleobase transport by recombinant human and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for the ENT2 helix 5-6 region in nucleobase translocation","volume":"277","author":"Yao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.117.079400_bib53","doi-asserted-by":"crossref","unstructured":"Young JD, Yao SY, Sun L, Cass CE, Baldwin SA (2008) Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica 38:995\u20131021.","DOI":"10.1080\/00498250801927427"},{"key":"10.1124\/dmd.117.079400_bib54","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1074\/jbc.M609421200","article-title":"Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family","volume":"282","author":"Zhou","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.117.079400_bib55","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1016\/S0021-9258(18)45638-4","article-title":"3\u2032-azido-3\u2032-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion","volume":"262","author":"Zimmerman","year":"1987","journal-title":"J Biol Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.117.079400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T18:03:47Z","timestamp":1740765827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624055144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0090955624055144"],"URL":"https:\/\/doi.org\/10.1124\/dmd.117.079400","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Structural and Molecular Features Involved in the Transport of 3\u2032-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.117.079400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The Author(s)","name":"copyright","label":"Copyright"}]}}